Table 2. Outcomes of percutaneous coronary interventions in patients with Kawasaki disease

Patient	Procedure	Treated lesion	Balloon size (mm)	Stent size (mm)	Burr size (mm)	Cx	Success	Reintervention	Neoaneruysm	Survival	F/U duration after PCI
1	PTCA Stent	LAD	3.5–4.5	DES 4.0 × 32	N/A	No	Yes	No	No	Yes	1.4
2	PTCRA Stent	LAD	2.5	DES 3.5 × 16	1.5	No	Yes	No	NA	Yes	2.9
3	PTCA	RCA	2.0–3.5	N/A	N/A	No	Yes	No	No	Yes	5.5
4	PTCA	RCA	2.5–4.0	N/A	N/A	No	Yes	No	No	Yes	8.5
5	PTCRA	LCx	N/A	N/A	1.5–2.0	No	Yes	No	No	No	1.8
6	PTCA	BGA	2.5–3.0	N/A	N/A	No	Yes	No	No	F/U loss	10.0
7	PTCA Stent	RCA	3.0	DES 3.0 × 24	N/A	No	Yes	Yes	No	F/U loss	0.8
	PTCA PTCRA	RCA	3.5	N/A	1.75	No	Yes	No	No
8	PTCA	LAD RCA	3.0–LAD 3.0–4.0 RCA	N/A	N/A	Type B RCA dissection	Yes	No	NA	Yes	13.7
9	PTCA	RCA	2.5	N/A	N/A	No	Yes	Yes	No	F/U loss	7.2
	PTCA Stent	RCA Restenosis	2.5–3.0	N/A	N/A	No	Yes	No	No
10	PTCA Stent	LAD	2.0	DES 2.75 × 13	N/A	No	Yes	No	NA	No	0.7
11	PTCA	RCA	2.0–2.5	N/A	N/A	No	Yes	No	NA	F/U loss	6.9

Cx: complications; PCI: percutaneous coronary intervention; PTCA: percutaneous transluminal coronary angioplasty; DES: drug-eluting stent; PTCRA: percutaneous transluminal coronary rotational ablation; LAD: left anterior descending artery; RCA: right coronary artery; LCx: left circumflex artery; BGA: bypass graft anastomosis; NA: not available; N/A: not applicable; F/U: follow-up.